Variant report
Variant | esv3467217 |
---|---|
Chromosome Location | chr4:78267917-78268476 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550456700 | chr4:78267934-78267935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs373858162 | chr4:78267938-78267939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551679893 | chr4:78267939-78267940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571486087 | chr4:78267950-78267951 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs112021932 | chr4:78267952-78267953 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181434591 | chr4:78268022-78268023 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs79549997 | chr4:78268038-78268039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77165781 | chr4:78268043-78268044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186061536 | chr4:78268064-78268065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190282648 | chr4:78268066-78268067 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs114851007 | chr4:78268107-78268108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558109091 | chr4:78268138-78268139 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs61169633 | chr4:78268141-78268142 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs139073585 | chr4:78268151-78268152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149907078 | chr4:78268176-78268177 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181928330 | chr4:78268178-78268179 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542763253 | chr4:78268194-78268195 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs10000660 | chr4:78268196-78268197 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs10002978 | chr4:78268215-78268216 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs17002564 | chr4:78268226-78268227 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
21 | rs565280407 | chr4:78268262-78268263 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2194119 | chr4:78268280-78268281 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs73827154 | chr4:78268338-78268339 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs113464981 | chr4:78268352-78268353 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572123112 | chr4:78268364-78268365 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534393273 | chr4:78268367-78268368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187566735 | chr4:78268368-78268369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548824840 | chr4:78268379-78268380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs80221769 | chr4:78268396-78268397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs199699536 | chr4:78268411-78268412 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190643524 | chr4:78268432-78268433 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs182148934 | chr4:78268433-78268434 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:78265400-78270200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr4:78266200-78270000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr4:78266400-78269400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr4:78266600-78269800 | Weak transcription | HMEC | breast |
5 | chr4:78267400-78269800 | Enhancers | Fetal Intestine Small | intestine |
6 | chr4:78267400-78270000 | Enhancers | Stomach Mucosa | stomach |
7 | chr4:78267400-78270200 | Enhancers | Fetal Intestine Large | intestine |
8 | chr4:78267600-78268800 | Enhancers | Pancreas | Pancrea |
9 | chr4:78268000-78268400 | Enhancers | HepG2 | liver |
10 | chr4:78268200-78269200 | Enhancers | Rectal Mucosa Donor 31 | rectum |
11 | chr4:78268400-78268600 | Enhancers | Colonic Mucosa | Colon |
12 | chr4:78268400-78268800 | Enhancers | A549 | lung |
13 | chr4:78268400-78268800 | Flanking Active TSS | HepG2 | liver |
14 | chr4:78268400-78269000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
15 | chr4:78268400-78269000 | Enhancers | Sigmoid Colon | Sigmoid Colon |
16 | chr4:78268400-78269400 | Enhancers | Duodenum Mucosa | Duodenum |